D2M Biotherapeutics Revenue

Biotechnology Research • Natick, Massachusetts, United States • 1-10 Employees

D2M Biotherapeutics revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,800,000
Total funding	No funding

Key Contact at D2M Biotherapeutics

Dong Zhang

Chief Science Officer, Co-founder

Company overview

Headquarters	22 Strathmore Rd, Natick, Massachusetts 01760, US
NAICS	541714
Keywords	Biotechnology, Immunology, Antibody Discovery, Human Genetics, Inflammatory Disease, Immunology-Oncology
Employees	1-10

D2M Biotherapeutics Email Formats

D2M Biotherapeutics uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@d2mbio.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@d2mbio.com	100%

About D2M Biotherapeutics

D2M Biotherapeutics is a startup biotech company located at Natick, MA. D2M (Data to Medicine) is a human-genetics driven biotherapeutics discovery company with a focus on immuno-oncology and inflammatory diseases. D2M has built up a platform of novel target discovery via deep mining the unprecedented disease genomic data. D2M is building up a sharply focused pipeline of monoclonal antibody or protein therapeutics targeting human genetics validated immune pathways. D2M's immediate focus is creating novel classes of biologics on cancers beyond anti-PD1/L1 IO therapies and rare immunology diseases currently with limited therapeutic options.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

D2M Biotherapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

D2M Biotherapeutics has never raised funding before.

Frequently asked questions

D2M Biotherapeutics is located in Natick, Massachusetts, US.

D2M Biotherapeutics generates an estimated annual revenue of $855,550. This revenue figure reflects the company's market position and business performance in its industry.

D2M Biotherapeutics has an estimated valuation of $2,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

D2M Biotherapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at D2M Biotherapeutics

Dong Zhang

Chief Science Officer, Co-founder

4.8

40,000 users